Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05959564 · ClinicalTrials.gov registry record · NA
A Chatbot Intervention for Reducing HPV Vaccine Hesitancy
A NA study, sponsored by University of Maryland, College Park.
- Completed
- Registry status
- NA
- Development phase
- 456
- Enrollment target
NCT05959564 is a NA study that has completed, run by University of Maryland, College Park. The registered enrollment target is 456 participants.
The verdict
NCT05959564, a NA study, has completed, sponsored by University of Maryland, College Park.
- COMPLETED
- Registry status
- NA
- Development phase
- 456 participants
- Enrollment target
Study Summary
The goal of this project is to test the efficacy of a chatbot intervention for reducing HPV vaccine hesitancy among African American parents. An online experiment will be conducted to test the effectiveness of the chatbot intervention with African American parents. Results of this project will inform future communication interventions for reducing vaccine hesitancy among African American parents.
Interventions
- BEHAVIORAL Personalized Chatbot Intervention
- BEHAVIORAL Non-Personalized Chatbot Intervention
- BEHAVIORAL No Chatbot Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 456 participants |
| Start Date | 2023-07-26 |
| Est. Completion | 2023-08-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05959564
The ClinicalTrials.gov registry entry for NCT05959564 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 456 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, College Park, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Personalized Chatbot Intervention is the first listed.
NCT05959564 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05959564 about?
NCT05959564 is a clinical study titled "A Chatbot Intervention for Reducing HPV Vaccine Hesitancy". The goal of this project is to test the efficacy of a chatbot intervention for reducing HPV vaccine hesitancy among African American parents. An online experiment will be conducted to test the effectiveness of the chatbot intervention with African American parents. Results of this project will infor...
What is the current status of trial NCT05959564?
This trial is currently completed. It is a NA study. The enrollment target is 456 participants. The study started on 2023-07-26. Estimated completion is 2023-08-08.
What interventions are being tested in trial NCT05959564?
The interventions under investigation include: Personalized Chatbot Intervention (BEHAVIORAL), Non-Personalized Chatbot Intervention (BEHAVIORAL), No Chatbot Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT05959564?
This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.